M&A
Vertex to Acquire Semma Therapeutics With a Goal of Developing Curative Cell-Based Treatments for Type 1 Diabetes
Vertex
PR-M09-19-NI-008Sep 04, 2019
Diabetes
Preclinical Studies Bode Well for Diabetes Drug from Semma Therapeutics
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M07-19-NI-009Jul 10, 2019